Binding mechanism of pentamidine derivatives with human serum acute phase protein α1-acid glycoprotein

Żołek, Teresa and Dömötör, Orsolya and Żabiński, Jerzy (2024) Binding mechanism of pentamidine derivatives with human serum acute phase protein α1-acid glycoprotein. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 266. ISSN 0141-8130

Preview

Text Zolek-Domotor_IJBM_2024.pdf Available under License Creative Commons Attribution. Download (7MB) | Preview

Abstract

Drug binding and interactions with plasma proteins play a crucial role in determining the efficacy of drug delivery, thus significantly impacting the overall pharmacological effect. AGP, the second most abundant plasma protein in blood circulation, has the unique capability to bind drugs and transport various compounds. In our present study, for the first time, we investigated whether AGP, a major component of the acute phase lipocalin in human plasma, can bind with pentamidine derivatives known for their high activity against the fungal pathogen Pneumocystis carinii. This investigation was conducted using integrated spectroscopic techniques and computer-based approaches. According to the results, it was concluded that compounds having heteroatoms (-NCH3) in the aliphatic linker and the addition of a –Br atom and a methoxy substituent at the C-2 and C-6 positions on the benzene ring, exhibit strong interactions with the AGP binding site. These compounds are identified as potential candidates for recognition by this protein. MD studies indicated that the tested analogues complexed with AGPs reach an equilibrium state after 60 ns, suggesting the stability of the complexes. This observation was further corroborated by experimental results. Therefore, exploring the interaction mechanism of pentamidine derivatives with plasma proteins holds promise for the development of bis-benzamidine-designed pharmaceutically important drugs. © 2024

Actions (login required)

Edit Item